We investigated the frequency of cardiac arrhythmias in patients suspected of having sleep apnea, and related them to the severity of apnea, snoring, and nocturnal hypoxemia. We prospectively studied 458 patients who had nocturnal polysomnography which included objective measurement of snoring (quantified by the number of snores per hour of sleep [snoring index (SI) 
Several studies show a linkage, and perhaps a causal association, between sleep apnea and heart disease.1 '6 There is evidence that patients with sleep apnea have higher mortality from cardiovascular causes than nonapneic individuals. One 
Polysomnographic Measurements
In all 458 patients, we carried out nocturnal polysomnography, which included measurements of EEG, submental, and anterior tibial EMG, oronasal flow using thermistors, chest wall and abdominal excursions using inductance plethysomography, oxygen saturation using finger oximeter, and single-lead electrocardiogram using modified precordial lead electrode. Snoring was measured in 388 patients using a microphone-sound meter system as described before. 14 In short, it was done by placing the microphone above the nasion (on the forehead), connecting the microphone to the sound meter ( All polysomnograms were scored in the usual manner. Apneas and hypopneas were identified as either complete or incomplete (greater than 50 percent) episodes of cessation of breathing lasting longer than 10 s. The number of such episodes per hour of sleep is termed apnea/hypopnea index (AHI). Similarly, snores were counted and the number of snores per hour of sleep is termed snoring index (SI); maximum nocturnal sound intensity (dBmax) was also recorded. Three indices of nocturnal oxygenation were used: lowest nocturnal oxygen saturation (LoO2S), mean nocturnal oxygen saturation (MnO2S), and percent of sleep time spent at oxygen saturation lower than 85 percent (TST85%). The latter measurement was available in 350 patients.
Cardiac rate and rhythm were assessed by examining the modified lead 2 electrocardiogram. Lowest, highest, and mean heart rates were recorded. Arrhythmias were classified according to their origin, as is usually done during standard polysomnography. Supraventricular arrhythmias were divided into sinus and atrial. The former included sinus bradycardia (rate less than 40/min), sinus tachycardia (rate >120/min), sinus arrhythmia (irregular rhythm with rate between 60 and 100/min), and sinus arrest (pause lasting longer than 2 s). The latter included wandering pacemaker, premature contractions, paroxysmal tachycardia, flutter, and fibrillation. Junctional rhythm, atrioventricular blocks, and bundle brunch blocks were identified and recorded separately. Ventricular arrhythmias included premature contractions, tachyeardia, flutter, and fibrillation.
Statistical Analysis
The goal of statistical analysis was to determine whether there is any relationship between the type of arrhythmia and the severity of apnea, nocturnal hypoxemia, and snoring. This was accomplished as follows.
First, we grouped all patients into the following "arrhythmia groups": (1) normal sinus rhythm (NSR), (2) supraventricular arrhythmia (SUPRA), which included sinus and atrial arrhythmias, (3) ventricular arrhythmia (VENT), which included premature ventricular contractions, atrioventricular block, and junctional beats, and (4) combined atrial and ventricular arrhythmias (COMB). We then used Kruskall-Wallis statistics to compare apnea (AHI), snoring (SI, dBmax), and oxygenation (LoO2S, MnO2S and TST85%) among the different arrhythmia groups.
Second, we examined the same problem from a different viewpoint, based on the hypothesis that patients with severe apnea, hypoxemia, and snoring are more likely to have cardiac arrhythmias than patients without apnea, hypoxemia, or snoring. To test this hypothesis we selected subgroups of patients "at the opposite ends of the spectrum" as far as the severity of their nocturnal events is concerned.
To examine the effect of snoring, we compared nonapneic nondesaturating light snorers (AHI -<10, SI <100, MnO2S >90%) with nonapneic nondesaturating heavy snorers (AHI -< 10, MnO2S >90%, SI >400).
To examine the effect of nocturnal hypoxemia, we compared nonapneic nonsnoring patients without nocturnal oxygen desaturation (AHI -'10, SI <100, MnO2S >90%) with nonapneic nonsnoring patients who desaturate at night (AHI C 10, SI <100, MnO2S <90%).
To examine the effect of apnea we compared nonapneic nondesaturating nonsnorers (AHI -<10, MnO2S >90%, SI <100) with apneic nondesaturating nonsnorers (AHI --40, MnO2S >90%, SI <100).
Chi-square statistics with Bonferroni corrections were used to compare the frequency of arrhythmias within each group. 1 All statistical analysis was done using SAS software (The SAS Institute; Gary, NC) version 6.04. Table 1 summarizes the characteristics of the patient population examined in this study. There were 336 men and 122 women. Most patients (244/458) did not have obstructive sleep apnea (OSA) (AHI < 10), 121/458 (26 percent) had AHI between 10 and 30, 41/458 (9 percent) had AHI between 30 and 50, and 52/458 patients (11 percent) had AHI >50. There were 82 patients with history of cardiac disease (hypertension, 51; previous myocardial infarction, 6; angina pectoris, 5; congestive heart failure, 4; coronary artery disease, 13; arrhythmia, 3, and 10 patients with chronic obstructive lung disease. The general categories of medications used by the patients are listed in Table 2 . We note that the majority of patients on medications did not have sleep apnea. Overall, there was no significant difference (by x2 statistics) between the proportion of apneic patients taking medications as compared with nonapneic patients.
RESULTS
Of the 458 patients, 228 had various conduction abnormalities, and of those 125 had sleep apnea (ie, AHI >10). This results in 58 percent (125/214) prevalence of arrhythmias among patients with OSA, which was significantly higher than 42 percent (103/214) prevalence of arrhythmias among patients without OSA (X2= 12.0, p<0.001). It should be noted, however, that the prevalence of arrhythmias among nonapneic patients was relatively high.
There were six patients with episodes of ventricular tachycardia; all of them had significant sleep apnea (mean AH1=42) and hypoxemia (LoO2S=71 percent, TST85%= 13 percent). None of the patients required urgent interventions.
The frequency of various arrhythmias is shown in Table 3 . We note that arrhythmias were significantly more common (X2=13.4, p<0.005) among patients with sleep apnea than among nonapneic controls. Of the 228 patients with arrhythmias, 174 had a single type of arrhythmia (ie, atrial, sinus, ventricular, or junctional), and 54 patients (33 apneic, 21 nonapneic) had combined arrhythmias, with two or more specific disturbances occurring over the course of the night (Table 3) . Figure 1 compares the mean values of AHI, SI, dBmax, MnO2, and TST85% in patients grouped into the arrhythmia categories as defined above. There was a significant difference in all of these variables except SI and dBmax between the groups, with Kur- skall-Wallis x2 ranging from 17 to 26, p<0.001. Table 4 shows the effect of snoring, nocturnal hypoxemia, and apnea on the prevalence of arrhythmias.
As may be seen from fect of snoring we selected nonapneic, nondesaturating light and heavy snorers, based on the snoring index of less than 100 or greater than 400. We found no significant difference in the prevalence of arrhythmias between these two groups (X2=0.001, p=0.971).
To examine the effect of nocturnal hypoxemia, we should ideally compare nonapneic nonsnoring nonhypoxemic group with nonapneic nonsnoring hypoxemic group. Not unexpectedly, however, there were no hypoxemic nonapneic nonsnorers-most hypoxemic patients either snore or have sleep apnea. Therefore, since snoring did not affect the prevalence of arrhythmias anyway, we examined the effect of hypoxemia on the frequency of cardiac arrhythmias by comparing nonapneic nonhypoxemic group with nonapneic hypoxemic group without any restriction on snoring. That is why the snoring index is relatively high in both groups (Table 4) , although the difference was not statistically significant by the Wilcoxon Rank Sum Test (p=0.1787). Hypoxemia was defined based on mean nocturnal oxygen saturation lower than 90 percent. The prevalence of supraventricular and ventricular arrhythmias was significantly higher in hypoxemic patients (x2=7.4, p=0.006).
The selection of subgroups to examine the effect of apnea on the prevalence of arrhythmias followed the same general guidelines as was used for hypoxemia. We compared nonhypoxemic nonapneic patients (mean nocturnal oxygen saturation >90%, AHI. 10) with nonhypoxemic significantly apneic (AHI240) patients, without any restrictions on snoring. The prevalence of arrhythmias, particularly the supraventricular and combined ones, was significantly higher (X2=9.2, p=0.002) in the apneic group. DISCUSSION This study shows that (1) patients with obstructive sleep apnea have higher prevalence of arrhythmia than nonapneic patients, (2) patients without arrhythmias, as a group, have less severe apnea and nocturnal hypoxemia than patients with arrhythmias, and (3) prevalence of arrhythmias is independent of snoring, but it is linked to sleep apnea and nocturnal hypoxemia. The study design has certain limitations which could conceivably influence some of our conclusions.
One of the drawbacks is the use of only a single lead (modified lead 2) ECG. This would underestimate the prevalence of abnormal axis, ST segment, T-wave, and QRS abnormalities, but it is not likely to affect the detection of conduction abnormalities or calculation of heart rate-which was the primary purpose of our study. Nevertheless, the absence of a full 12- lead ECG prevented us from more detailed classification of atrioventricular block and grading of premature ventricular contractions, as was done in previous investigations.10"1
Another drawback is that we did not examine normal (ie, nonsnoring, nonapneic) controls taken from the healthy population. Although we identified such subgroup among our 458 patients, they all came from sleep clinic population. It is possible that a patient found to be a nonapneic nonsnorer when sleeping in the laboratory on the night of the sleep study is a habitual snorer and has apneas when sleeping at home. This, however, is unlikely given the published results regarding the reproducibility of apnea and snoring.
On the other hand, our study has several unique features not present in previous investigations: (1) it includes a large group of subjects, all studied prospectively, (2) there were many nonapneic patients who could serve as controls, and (3) we measured snoring and related it to arrhythmias without the confounding effect of apnea and hypoxemia.
Only one large scale study, which could be compared with the present one, was performed in the past.10 The authors examined 400 patients with OSA for cardiac arrhythmias during sleep. They found that 48 percent of patients had cardiac arrhythmia recorded during the sleep study night. There were at least 75 patients (20 percent) who had ventricular CHEST / 106 / 2 / AUGUST, 1994 469 arrhythmias. No control group was studied, although there were 50 patients who served as their own controls and who improved after treatment with tracheotomy.
There is evidence suggesting that disturbances of cardiac rhythm, particularly ventricular ectopy, in OSA patients may not be related to sleep at all, being also present during wakefulness. Miller'l reviewed the results of 24 h Holter monitoring in 23 patients with OSA and found 78 percent prevalence of arrhythmias during sleep. Since many patients also had cardiac arrhythmias during wakefulness, however, the author concluded that the prevalence of serious arrhythmias during sleep is low. Although he did find a significantly higher prevalence of sinus arrhythmias during sleep compared with wakefulness, he was unable to show that for ventricular arrhythmias.
Our results show a significantly higher prevalence of cardiac arrhythmias, whether supraventricular or ventricular, among patients with OSA. Unlike other authors,'0"' we found that atrioventricular block, sinus pauses, and junctional rhythm were uncommon among our patients, seen in only 2 to 3 percent of those with OSA, vs 8 to 11 percent found by others.'0"'1 Although we found a statistically significant increase in the prevalence of cardiac arrhythmias among patients with OSA, it is important to note that nonapneic patients in our study also had a high prevalence of these arrhythmias (42 percent), similar to an observation by Flemons et al. 16 One possibility is that it reflects our particular patient population, all of whom were referred because of sleep disturbance and many of whom were on medications. Another possibility, however, is that it simply reflects the fact that nocturnal arrhythmias are common in the general population, occurring in about 50 percent of healthy people.17- '9 We believe that statistically significant increase in arrhythmias among patients with OSA found in the current study reflects their underlying disease. The data presented in Table 4 supports this hypothesis; furthermore, when we examined our patients with most serious arrhythmias-bigeminy, trigeminy, quadrigeminy, sinus pauses, asystole-we found that as a group they had most severe apnea (AHI>40) and hypoxemia (more than 19 percent of total sleep time spent at oxygen saturation lower than 85 percent).
Our results provide indirect evidence, but not a conclusive proof, that there is an independent relationship between cardiac arrhythmias, apnea, and nocturnal hypoxemia. We consider our evidence indirect because it is based on statistical analysis of subgroups matched for apnea and mean oxygen saturation, rather than on direct comparison of the frequency of arrhythmias in the same group of apneic hypoxemic subjects before and after elimination of apnea and hypoxemia. There is other evidence suggesting that apnea and hypoxemia may have independent, perhaps an additive, adverse effect on cardiac function. For example, nonapneic patients with nocturnal hypoxemia due to chronic obstructive lung disease have more ventricular ectopics during sleep.20'2' Although not directly dealing with arrhythmias, there is evidence that hypoxemia alone does not explain increases in blood pressure seen in sleep apnea,22 suggesting that apnea may have an additional, independent effect of the regulation of nocturnal sympathetic activity. Lastly, increased sympathetic activity, due to hypoxemia, and increased vagal activity, due to repetitive episodes of upper airway obstruction, may both have arrhythmogenic effect on the myocardium.23 It appears that combination of apnea and oxygen desaturation provide sufficient stress on the heart to predispose these patients toward development of ventricular arrhythmias.
Measurements of snoring in our large group of patients permit us to comment on the possible association between snoring and arrhythmias. This issue is currently of interest because of several studies indicating that snoring alone, without apneas, may be a risk factor for coronary artery and cerebrovascular disease.'2"3 We found no difference in the prevalence of arrhythmias between nonsnorers and heavy snorers. These observations imply that caution must be exercised in interpreting results of epidemiologic surveys comparing cardiac function in snorers and nonsnorers; in the absence of sleep studies, significant differences between the two groups may be from "contamination" of the snoring group by individuals with sleep apnea and hypoxemia.
We conclude that cardiac arrhythmias are more common in patients with sleep apnea than in nonapneics, that snoring alone, without sleep apnea or hypoxemia, does not significantly affect cardiac rhythm, and that presence of apnea and nocturnal hypoxemia is associated with increased prevalence of cardiac arrhythmias.
